webinar register page

Webinar banner
Cancer and COVID-19: The State of Clinical Trials During the COVID-19 Era
Join Dr. Bruce Johnson, Dana-Farber's Chief Clinical Research Officer, and his colleagues in clinical research for a live discussion and Q & A on:

• Dana-Farber operation of clinical trials in the COVID-19 era
• The impact of COVID-19 on clinical research and trials thus far
• The status of Scientific Review Boards, Institutional Review Boards
• Funding and industry partnerships
• Adaptations for patients who are undergoing treatment



DANA-FARBER CANCER INSTITUTE FACULTY

Bruce E. Johnson, MD
Chief Clinical Research Officer

Jeffrey Meyerhardt, MD, MPH, FASCO
Deputy Clinical Research Officer

Mary-Ellen Taplin, MD
Chair Executive Committee for Clinical Research

Kristen Legor, JD, RN, OCN
Associate Chief Nurse/Senior Director, Clinical Research


Need help registering? Call 1-800-553-3787

Jun 4, 2020 07:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading